Close Menu

NEW YORK (360Dx) – Abbott said today it has received CE marking for its Determine HBsAg 2 rapid diagnostic test used to detect hepatitis B surface antigen.

The firm said that the test provides results of HBV status in 15 minutes with an analytical sensitivity of 0.1 IU/mL, enabling clinicians to make prompt treatment decisions .

Abbott said that its rapid lateral flow immunoassay is highly sensitive, easy-to-use, and facilitates "linkage to care in every healthcare setting."

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.